• Explore /
  • Poster
  • / Frequency, severity and timing of common adverse events (AEs) with maintenance olaparib in patients (pts) with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).

Frequency, severity and timing of common adverse events (AEs) with maintenance olaparib in patients (pts) with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).

Abstract Poster

Authors

null

Ursula Matulonis

Dana-Farber Cancer Inst, Boston, MA

Ursula Matulonis , Michael Friedlander , Andreas Du Bois , Charlie Gourley , Ignace Vergote , Gordon J. S. Rustin , Clare L. Scott , Werner Meier , Ronnie Shapira-Frommer , Tamar Safra , Daniela Matei , Anitra Fielding , Emma McMurtry , Stuart Spencer , Helen Mann , David Parry , Jonathan A. Ledermann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT00753545

Citation

J Clin Oncol 33, 2015 (suppl; abstr 5550)

DOI

10.1200/jco.2015.33.15_suppl.5550

Abstract #

5550

Poster Bd #

108

Abstract Disclosures

Similar Posters

First Author: Jonathan A. Ledermann

First Author: Brian Dougherty

First Author: Frederic Selle

First Author: Andres Poveda